Systemic Hematologic Status Following Intraventricular Recombinant Tissue-Type Plasminogen Activator for Intraventricular Hemorrhage | Zendy

Daniel B. Herrick | Zendy; Wendy Ziai | Zendy; Carol B. Thompson | Zendy; Karen Lane | Zendy; Nichol McBee | Zendy; Daniel F. Hanley | Zendy

Open Access

Systemic Hematologic Status Following Intraventricular Recombinant Tissue-Type Plasminogen Activator for Intraventricular Hemorrhage

Author(s) -

Daniel B. Herrick,

Wendy Ziai,

Carol B. Thompson,

Karen Lane,

Nichol McBee,

Daniel F. Hanley

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.625749

Subject(s) - medicine , intraventricular hemorrhage , plasminogen activator , t plasminogen activator , fibrinogen , coagulopathy , fibrinolysis , tissue plasminogen activator , coagulation , thrombosis , disseminated intravascular coagulation , anesthesia , gestational age , pregnancy , genetics , biology

This is the first prospective evaluation of changes in systemic hematologic status following administration of intraventricular recombinant tissue-type plasminogen activator in patients with intraventricular hemorrhage (IVH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research